13F filer · CIK 1179392 ↗

Two Sigma

You are looking at Q2 2021. See the latest, Q2 2026 →

Reported value

$44.08B

+15% on the quarter before

Positions

3,960

1,099 new · 888 sold out

Top 10

6.1%

of the value

Est. gain

+$1.46B

on stocks held all quarter

Est. return

+7.4%

on those stocks since Q1 2021

Filed

Aug 16, 2021

On SEC EDGAR ↗

Positions as of Jun 30, 2021, from Two Sigma's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 14% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2021. Striped tiles are options.

SPDR S&P 500 ETF Tr0.8%
Roku Inc0.6%
Snap0.6%Qualcomm0.6%Visa Inc.0.6%Block0.6%Apple0.6%
Merck & Co Inc0.6%
Abbott Labs0.6%
Johnson & Johnson0.6%
Bristol-Myers Squibb Co0.6%
Coca Cola Co0.6%
Medtronic Plc0.6%
Csx Corp0.5%
Invesco Qqq Tr0.5%
Abbvie Inc0.5%
Starbucks Corp0.5%
Pfizer Inc0.5%
Target Corp0.5%
Costco Whsl Corp New0.5%
Amgen Inc0.5%
Canadian Natl Ry Co0.5%
Alphabet0.5%Airbnb0.5%

Largest buys

Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Starbucks Corp~$230.2MAdded · 0.0% → 0.5%+2,059,066 shares
  2. Amgen Inc~$229.1MNew · 0.0% → 0.5%+939,881 shares
  3. Airbnb~$225.1MNew · 0.0% → 0.5%+1,469,679 shares
  4. Costco Whsl Corp New~$219.3MAdded · 0.0% → 0.5%+554,345 shares
  5. Bristol-Myers Squibb Co~$205.7MAdded · 0.1% → 0.6%+3,078,135 shares
  6. Csx Corp~$205.0MAdded · 0.3% → 0.5%+6,391,041 shares
  7. Moderna Inc~$187.8MAdded · 0.0% → 0.5%+799,228 shares
  8. Norfolk Southn Corp~$180.1MAdded · 0.0% → 0.4%+678,694 shares
  9. Boston Scientific Corp~$167.0MAdded · 0.1% → 0.4%+3,904,441 shares
  10. Baidu~$166.6MNew · 0.0% → 0.4%+817,020 shares

Largest sells

Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Amazon~$245.0MSold out · 0.6% → 0.0%−79,195 shares
  2. Wayfair Inc~$218.4MSold out · 0.6% → 0.0%−693,753 shares
  3. Lowes Cos Inc~$211.9MSold out · 0.6% → 0.0%−1,114,179 shares
  4. Pepsico Inc~$210.6MSold out · 0.5% → 0.0%−1,489,121 shares
  5. SPDR S&P 500 ETF TrCALL~$205.3MCut · 0.5% → 0.0%−479,700 underlying
  6. Verizon Communications Inc~$201.4MCut · 0.6% → 0.1%−3,594,893 shares
  7. SPDR S&P 500 ETF TrPUT~$196.9MCut · 0.6% → 0.1%−460,000 underlying
  8. Microsoft~$180.0MCut · 0.6% → 0.2%−664,439 shares
  9. Meta~$177.2MCut · 0.4% → 0.0%−509,549 shares
  10. Splunk Inc~$161.1MCut · 0.6% → 0.2%−1,114,440 shares

Holdings

As of Jun 30, 2021. Changes are in shares against Mar 31, 2021, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
SPDR S&P 500 ETF TrTR UNIT · shares +11% · price +8.0%0.80%$353.0M+$23.6M
Roku IncCOM CL A · shares −25% · price +41.0%0.63%$279.4M+$81.2M
SnapCL A · shares +11% · price +30.3%0.62%$275.1M+$57.6M
QualcommCOM · shares +122% · price +7.8%0.60%$266.3M+$8.7M
Visa Inc.COM CL A · shares +0.9% · price +10.4%0.57%$253.2M+$23.7M
BlockCL A · shares +137% · price +7.4%0.57%$249.9M+$7.3M
AppleCOM · shares −6.6% · price +12.1%0.57%$249.3M+$27.0M
Merck & Co IncCOM · shares +31% · price +0.9%0.56%$248.3M+$1.7M
Abbott LabsCOM · shares +125% · price −3.3%0.56%$247.6M−$3.7M
Johnson & JohnsonCOM · shares −8.3% · price +0.2%0.56%$246.9M+$584,398
Bristol-Myers Squibb CoCOM · shares +519% · price +5.8%0.56%$245.3M+$2.2M
Coca Cola CoCOM · shares −1.2% · price +2.7%0.55%$244.4M+$6.3M
Medtronic PlcSHS · shares +11% · price +5.1%0.55%$243.5M+$10.6M
Csx CorpCOM · shares +552% · price −66.7%0.55%$242.1M−$74.4M
Invesco Qqq TrUNIT SER 1 · shares −16% · price +11.1%0.55%$240.5M+$23.9M
Abbvie IncCOM · shares −12% · price +4.1%0.54%$237.8M+$9.3M
Starbucks CorpCOM · shares +12,860% · price +2.3%0.53%$232.0M+$40,298
Pfizer IncCOM · shares −16% · price +8.1%0.53%$231.8M+$17.3M
Target CorpCOM · shares +66% · price +22.0%0.52%$231.0M+$25.1M
Costco Whsl Corp NewCOM · shares +2,027% · price +12.2%0.52%$230.2M+$1.2M
Amgen IncCOM · shares New0.52%$229.1M—
Canadian Natl Ry CoCOM · shares +44% · price −9.0%0.52%$227.8M−$15.7M
AlphabetCAP STK CL A · shares +34% · price +18.4%0.52%$227.1M+$26.2M
AirbnbCOM CL A · shares New0.51%$225.1M—
IBMCOM · shares −11% · price +10.0%0.50%$220.3M+$20.0M
Total · 3,960 positions100%$44.08B+$1.46B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q1 2021 to Q2 2021: 1,694 stocks held throughout, up $1.46B (+7.4%).

  1. Roku Inc+$81.2M+41%
  2. Snap+$57.6M+30%
  3. CrowdStrike+$46.9M+38%
  4. Albireo Pharma Inc+$37.5M+1,957%
  5. New Oriental Ed & Technology23:1 split+$31.2M+1,245%
  6. Canopy Growth Corp−$13.2M−25%
  7. Canadian Natl Ry Co−$15.7M−9%
  8. Canadian Pac Ry Ltd−$59.2M−80%
  9. Csx Corp−$74.4M−67%
  10. Alcoa Corp−$111.7M−97%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$200.00B$100.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$138.12B+11%SEC ↗
Q1 2026$123.93B+75%SEC ↗
Q4 2025$70.90B+6%SEC ↗
Q3 2025$67.17B+19%SEC ↗
Q2 2025$56.47B+21%SEC ↗
Q1 2025$46.79B+2%SEC ↗
Q4 2024$45.85B+0%SEC ↗
Q3 2024$45.63B+4%SEC ↗
Q2 2024$43.90B+3%SEC ↗
Q1 2024$42.61B−2%SEC ↗
Q4 2023$43.54B+17%SEC ↗
Q3 2023$37.17B−7%SEC ↗
Q2 2023$39.87B+14%SEC ↗
Q1 2023$34.99B+10%SEC ↗
Q4 2022$31.85B+8%SEC ↗
Q3 2022$29.43B−3%SEC ↗
Q2 2022$30.30B−11%SEC ↗
Q1 2022$33.88B−28%SEC ↗
Q4 2021$46.81B+5%SEC ↗
Q3 2021$44.75B+1%SEC ↗
Q2 2021$44.08B+15%SEC ↗
Q1 2021$38.44B+10%SEC ↗
Q4 2020$34.85B+24%SEC ↗
Q3 2020$28.17B+40%SEC ↗
Q2 2020$20.19B+64%SEC ↗
Q1 2020$12.28B−63%SEC ↗
Q4 2019$33.24B+12%SEC ↗
Q3 2019$29.72B−1%SEC ↗
Q2 2019$29.90B−3%SEC ↗
Q1 2019$30.85B+21%SEC ↗
Q4 2018$25.54B−30%SEC ↗
Q3 2018$36.69B+9%SEC ↗
Q2 2018$33.54B+12%SEC ↗
Q1 2018$30.04B−2%SEC ↗
Q4 2017$30.72B+9%SEC ↗
Q3 2017$28.21B+2%SEC ↗
Q2 2017$27.64B−7%SEC ↗
Q1 2017$29.70B+14%SEC ↗
Q4 2016$26.08B−5%SEC ↗
Q3 2016$27.59B+18%SEC ↗
Q2 2016$23.29B+11%SEC ↗
Q1 2016$20.99BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.